Evaluation of dermatologic disorders in HIV


Key articles

World Health Organization. Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults. 2014 [internet publication].Full text

Wilkins K, Turner R, Dolev JC, et al. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol. 2006 Feb;54(2):189-206. Abstract

Maurer TA. Dermatologic manifestations of HIV infection. Top HIV Med. 2005 Dec-2006 Jan;13(5):149-54. Abstract

Huiras E, Preda V, Maurer T, et al. Cutaneous manifestations of immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS. 2008 Jul;3(4):453-60. Abstract

Reference articles

1. Leslie KS, Levell NJ. Dermatologists, beacons of epidemics; past, present and future! Int J Dermatol. 2004 Jun;43(6):468-70. Abstract

2. World Health Organization. Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults. 2014 [internet publication].Full text

3. Paul S, Evans R, Maurer T, et al. Treatment of dermatological conditions associated with HIV/AIDS: the scarcity of guidance on a global scale. AIDS Res Treat. 2016 May 3;2016:3272483.Full text  Abstract

4. Mallon PW, Unemori P, Sedwell R, et al. In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J Infect Dis. 2005 May 15;191(10):1686-96.Full text  Abstract

5. Bastard JP, Caron M, Vidal H, et al. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet. 2002 Mar 23;359(9311):1026-31. Abstract

6. Rosenthal D, LeBoit PE, Klumpp L, et al. Human immunodeficiency virus-associated eosinophilic folliculitis. A unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol. 1991 Feb;127(2):206-9. Abstract

7. Maurer TA. Dermatologic manifestations of HIV infection. In: Cohen PT, Sande MA, Volberding PA, et al., eds. The AIDS knowledge base. Philadelphia, PA: Lippincott Williams & Wilkins; 1999:425-44.

8. Resneck JS Jr., Van Beek M, Furmanski L, et al. Etiology of pruritic papular eruption with HIV infection in Uganda. JAMA. 2004 Dec 1;292(21):2614-21.Full text  Abstract

9. Silverberg MJ, Neuhaus J, Bower M, et al. Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS. 2007 Sep 12;21(14):1957-63. Abstract

10. Molyneux E, Davidson A, Orem J, et al. The management of children with Kaposi sarcoma in resource limited settings. Pediatr Blood Cancer. 2013 Apr;60(4):538-42. Abstract

11. Müller M, Wandel S, Colebunders R, et al; IeDEA Southern and Central Africa. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis. 2010 Apr;10(4):251-61. Abstract

12. Miziara ID, Araujo Filho BC, Weber R. AIDS and recurrent aphthous stomatitis. Rev Bras Otorhinolaryngol. 2005 Jul-Aug;71(4):517-20.Full text  Abstract

13. Duvic M, Johnson TM, Rapini RP, et al. Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol. 1987 Dec;123(12):1622-32. Abstract

14. Menon K, Van Voorhees AS, Bebo BF Jr, et al; National Psoriasis Foundation. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010 Feb;62(2):291-9. Abstract

15. Healy E, Meenan J, Mulcahy F, et al. The spectrum of HIV related skin diseases in an Irish population. Ir Med J. Nov-Dec;86(6):188-90. Abstract

16. Coffin SE, Hodinka RL. Utility of direct immunofluorescence and virus culture for detection of varicella-zoster virus in skin lesions. J Clin Microbiol. 1995 Oct;33(10):2792-5.Full text  Abstract

17. Berrey MM, Schacker T, Collier AC, et al. Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS. J Infect Dis. 2001 May 15;183(10):1466-75. Abstract

18. Dunic I, Vesic S, Jevtovic DJ. Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy. HIV Med. 2004 Jan;5(1):50-4. Abstract

19. Ball LM, Harper JI. Atopic eczema in HIV-seropositive haemophiliacs. Lancet. 1987 Sep 12;2(8559):627-8. Abstract

20. Farthing CF, Staughton RC, Rowland Payne CM. Skin disease in homosexual patients with acquired immune deficiency syndrome (AIDS) and lesser forms of human T cell leukaemia virus (HTLV III) disease. Clin Exp Dermatol. 1985 Jan;10(1):3-12. Abstract

21. Scott C, Staughton RC, Bunker CJ, et al. Acne vulgaris and acne rosacea as part of immune reconstitution disease in HIV-1 infected patients starting antiretroviral therapy. Int J STD AIDS. 2008 Jul;19(7):493-5. Abstract

22. Winchester R, Bernstein DH, Fischer HD, et al. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med. 1987 Jan;106(1):19-26. Abstract

23. Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection. A review of twenty-seven patients. J Am Acad Dermatol. 1992 Oct;27(4):583-8. Abstract

24. Frean J, Arndt S, Spencer D. High rate of Bartonella henselae infection in HIV-positive outpatients in Johannesburg, South Africa. Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):549-50. Abstract

25. Lanjewar DN, Bhosale A, Iyer A. Spectrum of dermatopathologic lesions associated with HIV/AIDS in India. Indian J Pathol Microbiol. 2002 Jul;45(3):293-8. Abstract

26. Minga KA, Gberi I, Boka MB. Bacillary angiomatosis in an adult infected with HIV-1 at an early stage of immunodepression in Abidjan, Cote d'Ivoire [in French]. Bull Soc Pathol Exot. 2002 Mar;95(1):34-6. Abstract

27. Ciervo A, Petrucca A, Ciarrocchi S, et al. Molecular characterization of first human Bartonella strain isolated in Italy. J Clin Microbiol. 2001 Dec;39(12):4554-7.Full text  Abstract

28. Gazineo JL, Trope BM, Maceira JP, et al. Bacillary angiomatosis: description of 13 cases reported in five reference centers for AIDS treatment in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo. 2001 Jan-Feb;43(1):1-6.Full text  Abstract

29. Gutierrez-Galhardo MC, do Valle GF, Sa FC, et al. Clinical characteristics and evolution of syphilis in 24 HIV+ individuals in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo. 2005 May-Jun;47(3):153-7.Full text  Abstract

30. Gare J, Lupiwa T, Suarkia DL, et al. High prevalence of sexually transmitted infections among female sex workers in the eastern highlands province of Papua New Guinea: correlates and recommendations. Sex Transm Dis. 2005 Aug;32(8):466-73. Abstract

31. Hesketh T, Tang F, Wang ZB, et al. HIV and syphilis in young Chinese adults: implications for spread. Int J STD AIDS. 2005 Mar;16(3):262-6. Abstract

32. Nnoruka EN, Ezeoke AC. Evaluation of syphilis in patients with HIV infection in Nigeria. Trop Med Int Health. 2005 Jan;10(1):58-64.Full text  Abstract

33. Ryder N, Bourne C, Rohrsheim R. Clinical audit: adherence to sexually transmitted infection screening guidelines for men who have sex with men. Int J STD AIDS. 2005 Jun;16(6):446-9. Abstract

34. Dougan S, Elford J, Rice B, et al. Epidemiology of HIV among black and minority ethnic men who have sex with men in England and Wales. Sex Transm Infect. 2005 Aug;81(4):345-50.Full text  Abstract

35. Wong W, Chaw JK, Kent CK, et al. Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. Sex Transm Dis. 2005 Jul;32(7):458-63. Abstract

36. Fenton KA, Imrie J. Increasing rates of sexually transmitted diseases in homosexual men in Western Europe and the United States: why? Infect Dis Clin North Am. 2005 Jun;19(2):311-31. Abstract

37. del Amo J, Gonzalez C, Losana J, et al. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect. 2005 Feb;81(1):79-84.Full text  Abstract

38. Soni S, Horner P, Rayment M, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Mycoplasma genitalium (2018). Int J STD AIDS. 2019 Sep;30(10):938-950.Full text  Abstract

39. Rönn MM, Ward H. The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis. BMC Infect Dis. 2001 Dec;39(12):4554-7.Full text  Abstract

40. Lautenschlager S, Kemp M, Christensen JJ, et al. 2017 European guideline for the management of chancroid. Int J STD AIDS. 2017 Mar;28(4):324-329. Abstract

41. Bosch RJ, Rodrigo AB, Sanchez P, et al. Presence of Leishmania organisms in specific and non-specific skin lesions in HIV-infected individuals with visceral leishmaniasis. Int J Dermatol. 2002 Oct;41(10):670-5. Abstract

42. Choi CM, Lerner EA. Leishmaniasis: recognition and management with a focus on the immunocompromised patient. Am J Clin Dermatol. 2002;3(2):91-105. Abstract

43. Bittencourt A, Silva N, Straatmann A, et al. Post-kala-azar dermal leishmaniasis associated with AIDS. Braz J Infect Dis. 2002 Dec;6(6):313-6.Full text  Abstract

44. Agostoni C, Dorigoni N, Malfitano A, et al. Mediterranean leishmaniasis in HIV-infected patients: epidemiological, clinical, and diagnostic features of 22 cases. Infection. 1998 Mar-Apr;26(2):93-9. Abstract

45. Barrio J, Lecona M, Cosin J, et al. Leishmania infection occurring in herpes zoster lesions in an HIV-positive patient. Br J Dermatol. 1996 Jan;134(1):164-6. Abstract

46. Cooley TP. Non-AIDS-defining cancer in HIV-infected people. Hematol Oncol Clin North Am. 2003 Jun;17(3):889-99. Abstract

47. Allardice GM, Hole DJ, Brewster DH, et al. Incidence of malignant neoplasms among HIV-infected persons in Scotland. Br J Cancer. 2003 Aug 4;89(3):505-7. Abstract

48. Rabkin CS, Biggar RJ, Horm JW. Increasing incidence of cancers associated with the human immunodeficiency virus epidemic. Int J Cancer. 1991 Mar 12;47(5):692-6. Abstract

49. Wilkins K, Turner R, Dolev JC, et al. Cutaneous malignancy and human immunodeficiency virus disease. J Am Acad Dermatol. 2006 Feb;54(2):189-206. Abstract

50. Sasco AJ, Jaquet A, Boidin E, et al. The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One. 2010 Jan 11;5(1):e8621.Full text  Abstract

51. Wieland U, Silling S, Scola N, et al. Merkel cell polyomavirus infection in HIV-positive men. Arch Dermatol. 2011 Apr;147(4):401-6. Abstract

52. Tetzlaff MT, Nosek C, Kovarik CL. Epstein-Barr virus-associated leiomyosarcoma with cutaneous involvement in an African child with human immunodeficiency virus: a case report and review of the literature. J Cutan Pathol. 2011 Sep;38(9):731-9. Abstract

53. Yin X, Wu T, Yan Y, et al. Treatment for leiomyosarcoma and leiomyoma in children with HIV infection. Cochrane Database Syst Rev. 2010 May 12;(5):CD007665.Full text  Abstract

54. Maurer TA. Dermatologic manifestations of HIV infection. Top HIV Med. 2005 Dec-2006 Jan;13(5):149-54. Abstract

55. Lapinski, TW, Parfieniuk A, Rogalska-Plonska M, et al., Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function. Liver Int. 2009 Sep;29(8):1158-61. Abstract

56. Rajendran PM, Dolev JC, Heaphy MR, Jr., et al. Eosinophilic folliculitis: before and after the introduction of antiretroviral therapy. Arch Dermatol. 2005 Oct;141(10):1227-31.Full text  Abstract

57. Huiras E, Preda V, Maurer T, et al. Cutaneous manifestations of immune reconstitution inflammatory syndrome. Curr Opin HIV AIDS. 2008 Jul;3(4):453-60. Abstract

58. Kreuter A, Brockmeyer NH, Altmeyer P, et al. Anal intraepithelial neoplasia in HIV infection. J Dtsch Dermatol Ges. 2008 Nov;6(11):925-34. Abstract

59. Almagro M, Del Pozo J, Garcia-Silva J, et al. Eyelash length in HIV-infected patients. AIDS. 2003 Jul 25;17(11):1695-6. Abstract

60. Obuch ML, Maurer TA, Becker B, et al. Psoriasis and human immunodeficiency virus infection. J Am Acad Dermatol. 1992 Nov;27(5 Pt 1):667-73. Abstract

61. Colebunders R, Mann JM, Francis H, et al. Generalized papular pruritic eruption in African patients with human immunodeficiency virus infection. AIDS. 1987 Jul;1(2):117-21. Abstract

62. Bason MM, Berger TG, Nesbitt LT Jr. Pruritic papular eruption of HIV-disease. Int J Dermatol. 1993 Nov;32(11):784-9. Abstract

63. Sivayathorn A, Srihra B, Leesanguankul W. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. Ann Acad Med Singapore. 1995 Jul;24(4):528-33. Abstract

64. Ishii N, Nishiyama T, Sugita Y, et al. Pruritic papular eruption of the acquired immunodeficiency syndrome. Acta Derm Venereol.1994 May;74(3):219-20. Abstract

65. Parkin JM, Eales LJ, Galazka AR, et al. Atopic manifestations in the acquired immune deficiency syndrome: response to recombinant interferon gamma. Br Med J (Clin Res Ed). 1987 May 9;294(6581):1185-6.Full text  Abstract

66. Gelfand JM, Rudikoff D. Evaluation and treatment of itching in HIV-infected patients. Mt Sinai J Med. 2001 Sep-Oct;68(4-5):298-308. Abstract

67. Maurer T, Rodrigues LK, Ameli N, et al. The effect of highly active antiretroviral therapy on dermatologic disease in a longitudinal study of HIV type 1-infected women. Clin Infect Dis. 2004 Feb 15;38(4):579-84.Full text  Abstract

68. Redfield RR, James WD, Wright DC, et al. Severe molluscum contagiosum infection in a patient with human T cell lymphotrophic (HTLV-III) disease. J Am Acad Dermatol. 1985 Nov;13(5 Pt 1):821-4. Abstract

69. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998 Feb;177(2):361-7. Abstract

70. Centers for Disease Control and Prevention (CDC). Revised surveillance case definition for HIV infection--United States, 2014. MMWR Recomm Rep. 2014 Apr 11;63(RR-03):1-10.Full text  Abstract

71. Perronne C, Lazanas M, Leport C, et al. Varicella in patients infected with the human immunodeficiency virus. Arch Dermatol. 1990 Aug;126(8):1033-6. Abstract

72. Jura E, Chadwick EG, Josephs SH, et al. Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J. 1989 Sep;8(9):586-90. Abstract

73. Cohen PR, Grossman ME. Clinical features of human immunodeficiency virus-associated disseminated herpes zoster virus infection - a review of the literature. Clin Exp Dermatol. 1989 Jul;14(4):273-6. Abstract

74. Pahwa S, Biron K, Lim W, et al. Continuous varicella-zoster infection associated with acyclovir resistance in a child with AIDS. JAMA. 1988 Nov 18;260(19):2879-82. Abstract

75. Jacobson MA, Berger TG, Fikrig S, et al. Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1990 Feb 1;112(3):187-91. Abstract

76. Linnemann CC, Jr., Biron KK, Hoppenjans WG, et al. Emergence of acyclovir-resistant varicella zoster virus in an AIDS patient on prolonged acyclovir therapy. AIDS. 1990 Jun;4(6):577-9. Abstract

77. Cooper DA, Gold J, Maclean P, et al. Acute AIDS retrovirus infection. Definition of a clinical illness associated with seroconversion. Lancet. 1985 Mar 9;1(8428):537-40. Abstract

78. Wantzin GR, Lindhardt BO, Weismann K, et al. Acute HTLV III infection associated with exanthema, diagnosed by seroconversion. Br J Dermatol. 1986 Nov;115(5):601-6. Abstract

79. Rustin MH, Ridley CM, Smith MD, et al. The acute exanthem associated with seroconversion to human T-cell lymphotropic virus III in a homosexual man. J Infect. 1986 Mar;12(2):161-3. Abstract

80. Tindall B, Barker S, Donovan B, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med. 1988 Apr;148(4):945-9. Abstract

81. Sinicco A, Palestro G, Caramello P, et al. Acute HIV-1 infection: clinical and biological study of 12 patients. J Acquir Immune Defic Syndr. 1990;3(3):260-5. Abstract

82. Hulsebosch HJ, Claessen FA, van Ginkel CJ, et al. Human immunodeficiency virus exanthem. J Am Acad Dermatol. 1990 Sep;23(3 Pt 1):483-6. Abstract

83. Porras-Luque JI, Valks R, Casal EC, et al. Generalized exanthem with palmoplantar involvement and genital ulcerations: acute primary HIV infection. Arch Dermatol. 1998 Oct;134(10):1279, 1282. Abstract

84. Sun HY, Chen MJ, Hung CC, et al. Clinical presentations and virologic characteristics of primary human immunodeficiency virus type-1 infection in a university hospital in Taiwan. J Microbiol Immunol Infect. 2004 Oct;37(5):271-5. Abstract

85. Ortega KL, Rezende NP, Watanuki F, et al. Secondary syphilis in an HIV positive patient [in English/Spanish]. Med Oral. 2004 Jan-Feb;9(1):33-8.Full text  Abstract

86. Baniandres Rodriguez O, Nieto Perea O, Moya Alonso L, et al. Nodular secondary syphilis in a HIV patient mimicking cutaneous lymphoma [in Spanish]. An Med Interna. 2004 May;21(5):241-3. Abstract

87. Dave S, Gopinath DV, Thappa DM. Nodular secondary syphilis. Dermatol Online J. 2003;9:9. Abstract

88. Doris JP, Saha K, Jones NP, et al. Ocular syphilis: the new epidemic. Eye. 2006 Jun;20(6):703-5. Abstract

89. Passoni LF, de Menezes JA, Ribeiro SR, et al. Lues maligna in an HIV-infected patient. Rev Soc Bras Med Trop. 2005 Mar-Apr;38(2):181-4.Full text  Abstract

90. Janier M, Hegyi V, Dupin N, et al. 2014 European guideline on the management of syphilis. J Eur Acad Dermatol Venereol. 2014 Dec;28(12):1581-93. Abstract

91. Kingston M, French P, Higgins S, et al. UK national guidelines on the management of syphilis 2015. Int J STD AIDS. 2016 May;27(6):421-46. Abstract

92. Brites C, Weyll M, Pedroso C, et al. Severe and Norwegian scabies are strongly associated with retroviral (HIV-1/HTLV-1) infection in Bahia, Brazil. AIDS. 2020 Jun 14;16(9):1292-3. Abstract

93. Diven DG, Newton RC, Ramsey KM. Heightened cutaneous reactions to mosquito bites in patients with acquired immunodeficiency syndrome receiving zidovudine. Arch Intern Med. 1988 Oct;148(10):2296. Abstract

94. Penneys NS, Nayar JK, Bernstein H, et al. Chronic pruritic eruption in patients with acquired immunodeficiency syndrome associated with increased antibody titers to mosquito salivary gland antigens. J Am Acad Dermatol. 1989 Aug;21(2 Pt 2):421-5. Abstract

95. Melo NR, Taguchi H, Jorge J, et al. Oral Candida flora from Brazilian human immunodeficiency virus-infected patients in the highly active antiretroviral therapy era. Mem Inst Oswaldo Cruz. 2004 Jun;99(4):425-31.Full text  Abstract

96. Maurer T, Ponte M, Leslie K. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med. 2007 Sep 27;357(13):1352-3. Abstract

97. Mallal S, Phillips E, Carosi G, et al; PREDICT-1 Study Team. HLA-B*5701 screening for hypersensitivity to abacavir. N Engl J Med. 2008 Feb 7;358(6):568-79.Full text  Abstract

98. Potthoff A, Brockmeyer NH, Gelbrich G, et al; Competence Center Cardiac Insufficiency and the Competence Network HIV/AIDS. Lipodystrophy: a sign for metabolic syndrome in patients of the HIV-HEART study. J Dtsch Dermatol Ges. 2010 Feb;8(2):92-8. Abstract

99. Falutz J, Mamputu JC, Potvin D, et al. Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data. J Clin Endocrinol Metab. 2010 Sep;95(9):4291-304.Full text  Abstract

100. Sheth SH, Larson RJ. The efficacy and safety of insulin-sensitizing drugs in HIV-associated lipodystrophy syndrome: a meta-analysis of randomized trials. BMC Infect Dis. 2010 Jun 23;10:183.Full text  Abstract

Use of this content is subject to our disclaimer